This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Patrick Wild Centre | |
|---|---|
| Name | Patrick Wild Centre |
| Established | 2007 |
| Location | Edinburgh, Scotland |
| Affiliated with | University of Edinburgh, NHS Lothian |
| Focus | Developmental neurobiology; autism; genetic neurodevelopmental disorders; translational neuroscience |
Patrick Wild Centre is a translational research and clinical facility in Edinburgh focused on genetic and neurodevelopmental conditions including autism spectrum disorder, intellectual disability, and rare genetic syndromes. The Centre links basic science in molecular genetics, cellular neuroscience, and developmental neurobiology with clinical genomics, neuropsychology, and allied health services. It operates within the research and healthcare ecosystems associated with the University of Edinburgh, Royal Hospital for Children and Young People, Edinburgh, and Western General Hospital.
The Centre brings together investigators from departments such as Institute of Genetics and Cancer, University of Edinburgh, Centre for Clinical Brain Sciences, and the MRC Human Genetics Unit alongside clinicians from NHS Lothian and charities including SENSE and Scottish Autism. Its remit spans patient-focused diagnosis, phenotype–genotype correlation, cellular modelling using induced pluripotent stem cells and CRISPR-Cas9 gene editing, and early-phase intervention trials. Strategic priorities include rare variant discovery via large-scale sequencing consortia, neurodevelopmental outcome measures development with partners like the Scottish Government and involvement in multinational initiatives such as the Deciphering Developmental Disorders Study.
The Centre was established through philanthropic support and university–healthboard collaboration following advocacy by families and charities concerned with neurodevelopmental disability. Early links were forged with the Patrick Wild Centre for Research into Autism, Fragile X Syndrome and Intellectual Disabilities donors and academic groups at the University of Edinburgh. Over time the Centre developed cores for genomic diagnostics, neuroimaging, and cellular modelling, aligning with national efforts such as the 100,000 Genomes Project and research networks including the European Reference Network for Rare Neurological Diseases.
Research programs integrate teams from the Roslin Institute, the Edinburgh Cancer Research Centre (for shared genomics platforms), and cognitive neuroscience groups affiliated with the School of Philosophy, Psychology and Language Sciences, University of Edinburgh. Key strands include: - Genomics and Variant Interpretation: collaborative studies with the Wellcome Sanger Institute, Genomics England, and the UK Biobank to map pathogenic variants and copy-number variation. - Cellular and Molecular Neuroscience: modelling synaptic dysfunction via iPSC-derived neurons, organoids, and gene-editing pipelines developed with the Medical Research Council. - Systems Neuroscience and Neuroimaging: functional MRI and diffusion MRI studies in partnership with the Edinburgh Imaging Facility and the Centre for Clinical Brain Sciences. - Clinical Trials and Interventions: early-phase pharmacological and behavioural trials coordinated with the Medicines and Healthcare products Regulatory Agency and patient organizations including the Genetic Alliance UK.
Clinical services combine multidisciplinary assessment clinics, genetic counselling, and neurodevelopmental psychiatry clinics run in collaboration with Royal Hospital for Children and Young People, Edinburgh and community services in Lothian. Diagnostic pipelines incorporate chromosomal microarray, whole-exome sequencing, and whole-genome sequencing through links with NHS Scotland Genetics Services and data interpretation networks like DECIPHER. Outcome measurement and service evaluation are co-produced with advocacy groups such as Contact (Charity) and Rare Disease UK.
The Centre hosts postgraduate training, doctoral studentships, and clinical fellowships affiliated with the University of Edinburgh Medical School, the Edinburgh Clinical Academic Track, and professional training from the Royal College of Psychiatrists and the Royal College of Paediatrics and Child Health. Workshops, seminars, and public engagement events are run jointly with the Scottish Science Centre and patient groups including Autism Rights Group Highland to support workforce development and family education.
Strategic partnerships extend to international academic centres such as Harvard Medical School, Karolinska Institutet, and University of Toronto for collaborative grants and exchange. The Centre contributes to consortia including the International Rare Diseases Research Consortium and the European Molecular Biology Laboratory networks, and works with funders like the Wellcome Trust, the National Institute for Health and Care Research, and charitable donors including the Patrick Wild Centre Fund. Patient and family partnerships include Genetic Disorders UK and local advocacy organizations to co-design research priorities.
Facilities include wet labs for molecular biology, cell culture suites for iPSC work, clinical assessment suites, neuroimaging access via the Edinburgh Imaging Facility, and bioinformatics cores linked to the Edinburgh Genomics service. Funding derives from competitive research councils, biomedical charities, philanthropic endowments, and NHS research budgets administered through the Chief Scientist Office (Scotland). The Centre sustains translational pipelines by leveraging core facilities at the University of Edinburgh and collaborative grant funding with international partners.
Category:Research institutes in Scotland Category:Institutions affiliated with the University of Edinburgh